Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADC Agree

Post-Mkt 05-11 19:49:26 EDT

76.39

+0.17

+0.22%

盘后76.39

+0.000.00%

18:25 EDT

High77.12	Low76.20	Vol724.98K
Open76.48	D1 Closing76.22	Amplitude1.21%
Mkt Cap9.17B	Tradable Cap8.28B	Total Shares120.03M
T/O55.55M	T/O Rate0.67%	Tradable Shares108.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"Agree","latestPrice":76.39,"timestamp":1778529600000,"preClose":76.22,"halted":0,"volume":724978,"hourTrading":{"tag":"盘后","latestPrice":76.39,"preClose":76.39,"latestTime":"18:25 EDT","volume":22984,"amount":1755726.38488,"timestamp":1778538313422,"change":0,"changeRate":0,"amplitude":0.014662},"delay":0,"changeRate":0.002230385725531379,"floatShares":108366822,"shares":120028300,"eps":1.85165,"marketStatus":"Post-Mkt","change":0.17,"latestTime":"05-11 19:49:26 EDT","open":76.48,"high":77.12,"low":76.2,"amount":55552548.466340005,"amplitude":0.01207,"askPrice":77.91,"askSize":32,"bidPrice":75,"bidSize":5,"shortable":3,"etf":0,"ttmEps":1.85165,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1778544000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":76.22,"dividendRate":0.040681,"preHourTrading":{"tag":"盘前","latestPrice":76.35,"preClose":76.22,"latestTime":"09:29 EDT","volume":4,"amount":307.321504,"timestamp":1778506171128,"change":0.13,"changeRate":0.001706,"amplitude":0.021648},"postHourTrading":{"tag":"盘后","latestPrice":76.39,"preClose":76.39,"latestTime":"18:25 EDT","volume":22984,"amount":1755726.38488,"timestamp":1778538313422,"change":0,"changeRate":0,"amplitude":0.014662},"volumeRatio":0.690261,"impliedVol":0.2474,"impliedVolPercentile":0.8845},"requestUrl":"/m/hq/s/ADC/wiki","defaultTab":"wiki","newsList":[{"id":"2634232793","title":"Press Release: Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232793","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232793?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:05","pubTimestamp":1778529900,"startTime":"0","endTime":"0","summary":"-- Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody. prostate cancer  is progressing well with the interim analysis. -- Positive results from the investigator-sponsored study of FG-3246 in. combination with enzalutamide in patients with mCRPC were presented at. ASCO GU in February 2026, further validating key Phase 2 monotherapy. -- Pivotal Phase 3 trial protocol of roxadustat for the treatment of anemia. in patients with lower-risk myelodysplastic syndromes  and high. -- Kyntra Bio to host conference call and webcast presentation today at 5:00. Key Highlights of First Quarter, Recent Developments, and Upcoming Milestones. targeting CD46, in mCRPC is actively enrolling and remains on track for. -- Higher tumor uptake of FG-3180 was numerically associated with","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211327993.USD","LU0052756011.USD","BK4109","BK4099","R","KYNB","LU1267930227.SGD","ADC","BK4231","BK4555","LU1267930490.SGD","DD","03160","LU0310800965.SGD","BK4604","LU0310799852.SGD","BK4022","BK4588","LU0128525689.USD","LU0211328371.USD","TM","BK4504","LU2236285917.USD","BK4232","BK4139","BK4585","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634325842","title":"Press Release: ArriVent BioPharma Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634325842","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634325842?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:01","pubTimestamp":1778529660,"startTime":"0","endTime":"0","summary":"-- Topline global pivotal Phase 3 data for firmonertinib in first-line EGFR. -- IND clearance of ARR-002, ArriVent's dual-targeting MUC16/NaPi2b. tetravalent ADC, advances into the clinic and plans to dose its first. patient in 2H 2026, initially for ovarian and endometrial cancers. -- ARR-002's superior anti-tumor activity and favorable tolerability vs.single-target or bivalent approaches in preclinical ovarian cancer models. Dr. Yao continued, \"We also presented preclinical data for our antibody-drug conjugate , ARR-002 at AACR. This novel MUC16/NaPi2b dual-targeting tetravalent ADC demonstrated synergistic anti-tumor activity compared to single-target and bivalent ADCs, along with a favorable tolerability profile, supporting its best-in-class potential. Following the recent clearance of our Investigational New Drug  application by the U.S. Food and Drug Administration , we plan to initially advance ARR-002 into the clinic for ovarian and endometrial cancers. Our balance sheet contin","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP","IND","ADC","BK4139","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634289940","title":"RBC Capital Reaffirms Their Buy Rating on ADC Therapeutics (ADCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634289940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634289940?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:17","pubTimestamp":1778501844,"startTime":"0","endTime":"0","summary":"In a report released on May 8, Leonid Timashev from RBC Capital maintained a Buy rating on ADC Therapeutics, with a price target of $6.00. The comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-adc-therapeutics-adct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-adc-therapeutics-adct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","ADCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634007407","title":"CSPC’s ADC SYS6010 Wins New Breakthrough Status in China Esophageal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2634007407","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634007407?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:12","pubTimestamp":1778494357,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group ( ($HK:1093) ) has provided an update. CSPC Pharmaceutical Group said its independently developed drug SYS6010, a humanis...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cspcs-adc-sys6010-wins-new-breakthrough-status-in-china-esophageal-cancer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cspcs-adc-sys6010-wins-new-breakthrough-status-in-china-esophageal-cancer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634427306","title":"Hansoh Pharmaceutical Wins Breakthrough Therapy Status for Esophageal Cancer ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2634427306","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634427306?lang=en_us&edition=fundamental","pubTime":"2026-05-11 08:08","pubTimestamp":1778458129,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited ( ($HK:3692) ) has shared an update. Hansoh Pharmaceutical has received Breakthrough-Therapy-Designated...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hansoh-pharmaceutical-wins-breakthrough-therapy-status-for-esophageal-cancer-adc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hansoh-pharmaceutical-wins-breakthrough-therapy-status-for-esophageal-cancer-adc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","BK4231","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634086428","title":"AI Can't Agree on Which Jobs AI Might Destroy -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2634086428","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634086428?lang=en_us&edition=fundamental","pubTime":"2026-05-11 00:00","pubTimestamp":1778428800,"startTime":"0","endTime":"0","summary":"The numbers that researchers have been using to predict which jobs could be lost to artificial intelligence may be unreliable. One of the culprits could be AI itself.Worries about how AI will affect the job market have become one of the most pressing economic questions of our time, and understanding the limits of any forecasts is crucial. Policymakers want to know which workers could be displaced and need support. Schools, students and parents want to know which careers might be \"AI-proof.\". To gauge which jobs might be at risk, economists have built \"exposure scores\" using a task-based framework. The Labor Department maintains a database of what workers in different occupations actually do: Bakers need to mix dough and put it in the oven, financial analysts need to assess companies, and so on. Researchers try to determine which of those tasks AI could significantly speed up.The larger the share of tasks that AI could do, the more exposed that job is. These scores have proliferated wid","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","BK4231","BK4587","AIYY","BK4585","AIPO","CHAT","BK4080","BK4551","ARTY","BK4528","AI","ADC","AGIX","BK4023","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634913244","title":"Trump Brokers Russia-Ukraine Ceasefire As Putin And Zelenskyy Agree To Massive Prisoner Swap: 'Hopefully, It Is The Beginning Of The End...'","url":"https://stock-news.laohu8.com/highlight/detail?id=2634913244","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634913244?lang=en_us&edition=fundamental","pubTime":"2026-05-09 10:38","pubTimestamp":1778294280,"startTime":"0","endTime":"0","summary":"Trump announced a temporary Russia-Ukraine ceasefire and major prisoner swap after securing agreement from Putin and Zelenskyy.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/05/08/Washington--Feb--28--2025-President-Dona.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/05/08/Washington--Feb--28--2025-President-Dona.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/politics/26/05/52433929/trump-brokers-russia-ukraine-ceasefire-as-putin-and-zelenskyy-agree-to-massive-prisoner-swap-hopefully-it-is-the-beginning-of-the-end","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/politics/26/05/52433929/trump-brokers-russia-ukraine-ceasefire-as-putin-and-zelenskyy-agree-to-massive-prisoner-swap-hopefully-it-is-the-beginning-of-the-end","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["ADC","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634464213","title":"Russia and Ukraine Agree to Three-Day Ceasefire, Trump Says -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2634464213","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634464213?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:16","pubTimestamp":1778271360,"startTime":"0","endTime":"0","summary":"By Brian Schwartz, Lara Seligman and Anastasiia Malenko. Russia and Ukraine have agreed to a three-day cease-fire and prisoner exchange, President Trump announced Friday, the latest pause in fighting during the more than four yearslong war.The news comes just a month after the most recent temporary cease-fire, a 32-hour pause for Orthodox Easter when both sides accused the other of breaking the truce. Last year, Russian President Vladimir Putin ordered a cease-fire in honor of Victory Day commemorations. Ukrainian President Volodymyr Zelensky accused Russian forces of violating the cease-fire and offered to introduce a month-long unconditional truce, a proposal rejected by the Kremlin.Ukraine has demonstrated an increased ability to strike targets deep inside Russia with drones in recent months, which has heightened concerns within the Kremlin about security for the parade, leading to plans being scaled back. It will go ahead without tanks and other military hardware being displayed. K","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","ADC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633918455","title":"Press Release: Assertio and Garda Mutually Agree to Delay Launch of Tender Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2633918455","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633918455?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:00","pubTimestamp":1778241600,"startTime":"0","endTime":"0","summary":"Assertio Holdings, Inc.  , today announced that it has reached a mutual agreement with Garda Therapeutics, Inc.  to delay the launch of the previously announced tender offer to acquire all outstanding shares of Assertio to May 14, 2026.As previously announced on May 4, 2026, Assertio has entered into an amended and restated merger agreement  to be acquired by Garda for $21.80 per share in cash, or total cash consideration of $153.2 million. The Company expects to file a Schedule 14D-9 in connection with the tender offer on May 14, 2026. In addition, Assertio will delay the launch of the previously announced tender offer for all outstanding Convertible Senior Notes until May 14, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4080","BK4007","ASRT","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633455764","title":"ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633455764","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633455764?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:00","pubTimestamp":1778241600,"startTime":"0","endTime":"0","summary":"- Data from Phase 1b/2 trial of evorpacept + zanidatamab presented at ESMO Breast Cancer 2026 showed all patients with confirmed HER2-positive disease and high CD47 expression experienced durable resp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/08/3291041/0/en/ALX-Oncology-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","ALX","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150179988","title":"SKB BIO's Core TROP2 ADC Therapy Sac-TMT Gains NMPA Acceptance for New Indication Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1150179988","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150179988?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:22","pubTimestamp":1778235723,"startTime":"0","endTime":"0","summary":"Kelun-Bota Biopharma (06990) has announced that a new supplemental New Drug Application (sNDA) for its TROP2-targeting antibody-drug conjugate (ADC), sacituzumab govitecan (sac-TMT, also known as...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK1161","IPOS","ADC","06990","BK4231","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633678172","title":"NextCure Provides Business Update and Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633678172","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633678172?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184300,"startTime":"0","endTime":"0","summary":"SIM0505/CDH6 ADC dose optimization initiated in gynecologic cancersSIM0505 Phase 1 dose escalation study data to be presented at ASCO 2026 LNCB74 Phase 1 dose escalation trial update planned in second","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3290534/0/en/NextCure-Provides-Business-Update-and-Reports-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","PROC","BK4080","ADC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633126004","title":"Is Agree Realty (ADC) Price Fair After Steady Returns And Shifting REIT Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2633126004","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633126004?lang=en_us&edition=fundamental","pubTime":"2026-05-07 21:46","pubTimestamp":1778161578,"startTime":"0","endTime":"0","summary":"If you are wondering whether Agree Realty stock at around US$76.50 offers good value today, this breakdown will help you judge whether the current price lines up with the underlying fundamentals.\nRecent returns have been steady, with the stock showing 0.2% over the past week, 1.3% over the last month, 6.1% year to date, 4.7% over 1 year, 29.8% over 3 years and 40.3% over 5 years.\nRecent news coverage has centered on Agree Realty in the context of broader real estate market sentiment and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/is-agree-realty-adc-price-fair-after-steady-returns-and-shif","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/is-agree-realty-adc-price-fair-after-steady-returns-and-shif","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CFA.SI","BK4080","REIT","ADC","BK7095","BK6142","ADC.AU","BK4231","DCF","8C8U.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633231391","title":"Indonesia, Singapore Agree to Boost Defense Ties in Jakarta Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2633231391","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633231391?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:06","pubTimestamp":1778155594,"startTime":"0","endTime":"0","summary":"Sjafrie explained that Singapore is a strategic partner for Indonesia in the field of military cooperation.","market":"fut","thumbnail":"https://statik.tempo.co/data/2026/04/24/id_1470428/1470428_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/04/24/id_1470428/1470428_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2102450/indonesia-singapore-agree-to-boost-defense-ties-in-jakarta-meeting","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2102450/indonesia-singapore-agree-to-boost-defense-ties-in-jakarta-meeting","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["ADC","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144669","title":"ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144669","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144669?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:00","pubTimestamp":1778155200,"startTime":"0","endTime":"0","summary":"Superior efficacy and favorable tolerability in animal models support the potential of ARR-002 to overcome limitations of single-target approachesPhase 1 initiation expected in the second half of 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3289913/0/en/ArriVent-Announces-IND-Clearance-for-Novel-Tetravalent-MUC16-NaPi2b-Targeting-ADC-ARR-002-with-Initial-Focus-in-Ovarian-and-Endometrial-Cancers.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0012050646.USD","LU2380233275.USD","LU1721429741.USD","LU2308191902.HKD","IND","ADC","BK4110","BK4080","LU0106261612.USD","LU0256331488.USD","BK4231","DAR","LU1721429402.USD","LU1803068623.USD","LU2211817866.USD","BK4189","ARR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144651","title":"Press Release: Whitehawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144651","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144651?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:00","pubTimestamp":1778155200,"startTime":"0","endTime":"0","summary":"Phase 1 trials for HWK-007 and HWK-016 are ongoing; an IND submission for HWK-206 is on track for mid-2026. Cash, cash equivalents and short-term investments balance of $123.0 million as of March 31, 2026, anticipated to fund operations into 2028. MORRISTOWN, N.J., May 7, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. , a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate  cancer treatments, today announced financial results for the quarter ended March 31, 2026, and provided recent corporate highlights.\"This quarter reflects continued progress across our pipeline as we advance Phase 1 dose-escalation studies for HWK-007 and HWK-016, with a third IND planned for HWK-206 mid-year,\" said Dave Lennon, PhD, President and CEO of Whitehawk Therapeutics. \"We remain focused on high quality execution as we build toward initial data anticipated in 1H 2027, with the goal of delivering m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4080","LENZ","BK4139","ADC","BK4539","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633609321","title":"InnoCare Announces Approval of Clinical Trial of Novel CDH7 targeted ADC ICP-B208 in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2633609321","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633609321?lang=en_us&edition=fundamental","pubTime":"2026-05-07 10:25","pubTimestamp":1778120700,"startTime":"0","endTime":"0","summary":"BEIJING, May  06, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3289549/0/en/InnoCare-Announces-Approval-of-Clinical-Trial-of-Novel-CDH7-targeted-ADC-ICP-B208-in-China.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1223082519.USD","ADC","CDE","BK4231","BK4080","LU1223082196.USD","BK4017","IND","LU1223083913.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633133693","title":"PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633133693","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633133693?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:00","pubTimestamp":1778068800,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., May  06, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the imm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288773/37149/en/PDS-Biotech-Announces-Conference-Call-and-Webcast-for-2026-First-Quarter-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","PDS","XBI","BK4581","BK4588","BK4231","BK4585","BK4092","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633949426","title":"ADC Therapeutics Price Target Maintained With a $6.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2633949426","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633949426?lang=en_us&edition=fundamental","pubTime":"2026-05-05 22:39","pubTimestamp":1777991940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 10:39 ET (14:39 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633794957","title":"Xanadu, EV Group Agree to Develop Wafer Bonding Processes to Scale Photonic Quantum Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2633794957","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633794957?lang=en_us&edition=fundamental","pubTime":"2026-05-05 22:19","pubTimestamp":1777990762,"startTime":"0","endTime":"0","summary":"Xanadu Quantum Technologies (XNDU) and EV Group agreed to a partnership to develop heterogeneous integration and wafer bonding processes to further the scalability of photonic quantum systems, the com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","BK4080","XNDU","ADC"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.agreerealty.com","stockEarnings":[{"period":"1week","weight":-0.0018},{"period":"1month","weight":-0.007},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0383},{"period":"1year","weight":0.0165},{"period":"ytd","weight":0.0582}],"compareEarnings":[{"period":"1week","weight":0.0235},{"period":"1month","weight":0.0911},{"period":"3month","weight":0.0681},{"period":"6month","weight":0.0993},{"period":"1year","weight":0.3054},{"period":"ytd","weight":0.0817}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agree Realty Corporation (the Company), a Maryland corporation, is a fully integrated real estate investment trust (REIT) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (GLA) of approximately 44.9 million square feet.","yearOnYearQuotes":[{"month":1,"riseRate":0.59375,"avgChangeRate":-0.003579},{"month":2,"riseRate":0.46875,"avgChangeRate":0.002186},{"month":3,"riseRate":0.5625,"avgChangeRate":0.012831},{"month":4,"riseRate":0.59375,"avgChangeRate":0.003425},{"month":5,"riseRate":0.484848,"avgChangeRate":0.01481},{"month":6,"riseRate":0.65625,"avgChangeRate":0.010123},{"month":7,"riseRate":0.65625,"avgChangeRate":0.022845},{"month":8,"riseRate":0.46875,"avgChangeRate":0.002201},{"month":9,"riseRate":0.46875,"avgChangeRate":-0.006321},{"month":10,"riseRate":0.5625,"avgChangeRate":-0.000339},{"month":11,"riseRate":0.65625,"avgChangeRate":0.003584},{"month":12,"riseRate":0.46875,"avgChangeRate":0.00994}],"exchange":"NYSE","name":"Agree","nameEN":"Agree"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agree,ADC,Agree股票,Agree股票老虎,Agree股票老虎国际,Agree行情,Agree股票行情,Agree股价,Agree股市,Agree股票价格,Agree股票交易,Agree股票购买,Agree股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}